Accelerate Diagnostics Inc. Stock
There is an upward development for Accelerate Diagnostics Inc. compared to yesterday, with an increase of €0.015 (1.740%).
Pros and Cons of Accelerate Diagnostics Inc. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Accelerate Diagnostics Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Accelerate Diagnostics Inc. | 1.740% | 23.741% | 2.381% | -89.512% | -76.243% | -98.590% | - |
MicroVision Inc | 5.930% | 10.556% | -6.733% | -16.964% | -41.857% | -88.406% | 64.251% |
Fonar Corp. New | -0.670% | 1.361% | -20.745% | 5.674% | -15.819% | 4.930% | -15.235% |
Allscripts Healthcare | 5.800% | 5.797% | 12.308% | -32.407% | -21.081% | -42.063% | -16.409% |
Comments
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) had its "outperform" rating re-affirmed by analysts at William Blair.
Show more
Ratings data for AXDX provided by MarketBeat
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for AXDX provided by MarketBeat